Webtoon, Carlsberg, Tempus: Trending Stocks

Webtoon in dreamland after Disney deal, Carlsberg see major dent and Tempus AI gets the backing of Cathie Wood and Nancie Pelosi on Market Sunrise's Trending Tickers.

Video Transcript

00:00 Speaker A

Time for our trending tickers and I told you about a stock that was up over 80%. What was it? Well, it was Webtoon. Disney has reached an agreement with Webtoon entertainment to host a variety of its iconic IPs, such as Star Wars and Marvel on its platforms. Initially founded in South Korea, but now listed in New York and based in LA, Webtoon specializes in vertical scroll comics, primarily for viewing on mobile phones. Shares jumped over 80%, as I said, and continue to be positive in the pre-market. Webtoon has over 150 million monthly users and reported $348.3 million in revenue in its Q2 earnings in June, an 8.5% increase. It's also partnered with another favorite of mine, Crunchyroll, the anime streaming service and DC Comics, the home of Batman and Superman. Moving on to a very different stock now and one that's suffering this morning, Carlsberg. Shares of the Danish beer maker are down around 6.5%, dragged down by disappointment, it's over 7% now, dragged down by disappointment from its half-year earnings. Carlsberg reported just 2.3% operating profit growth, below analyst expectations of 7.35 billion Danish crowns, and volumes dropped nearly 1.7%. Despite raising its full year guidance, management warned that consumer demand is unlikely to improve through the remainder of 2025. Now Carlsberg is the third major brewer to acknowledge struggles in recent weeks after AB Inbev and Heineken. Expect further volatility in this sector as investors and consumers' tastes appear to shift away from established brands. Now onto Tempus AI, the startup backed by Cathy Woods and Nancy Pelosi has been rising in the past day and is now trading around the $70 mark. Tempus beat Q2 expectations and is riding the wave of renewed optimism around healthcare AI. Tempus is developing what it calls precision medicine systems to collect and analyze health data for the diagnosis and treatment of diseases. The stock is benefiting from being one of the largest positions in Ark Investments portfolio. That's Kathy Woods' fund, and some analysts see it rising much further from here.

查看留言